Clinical Trials in Spain

• A study to test how well BI 3720931 is tolerated and whether it improves lung function in people with cystic fibrosis (LenticlairTM 1) Ended
  2023-503281-23-00 Phase I (FiH) Cystic fibrosis Boehringer Ingelheim Espana S.A.; Boehringer Ingelheim International GmbH
• A study to learn how well bimekizumab works and how safe it is in adults with psoriatic arthritis Ended
  2024-511738-11-00 Phase III Psoriatic arthritis UCB Biopharma
• A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of Vosoritide in Children Wit… Ended
  2024-513129-22-00 Phase III Hypochondroplasia Biomarin Pharmaceutical Inc.
• A trial to test the effect of leniolisib in children from 1 to 6 years of age with APDS Ended
  2022-502180-38-00 Phase III Activated Phosphoinositide 3-Kinase Delta Syndrome Pharming Technologies B.V.
• Bioequivalence clinical trial of two formulations of linagliptin/metformin. Ended
  2024-516081-11-00 Healthy volunteers Laboratorios Normon S.A.
• A clinical study of sotatercept in people with pulmonary arterial hypertension (MK-7962-024) Ended
  2024-512278-92-00 Phase II Pulmonary Arterial Hypertension (PAH) Merck Sharp & Dohme LLC
• A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in … Ended
  2024-511057-22-00 Phase III Major Depressive Disorder (MDD) with Moderate-to-severe Anhe… Janssen Cilag International
• A phase I study of [177Lu]Lu-FF58 in patients with advanced solid tumors Ended
  2022-502367-37-00 Phase I (FiH) Recurrent glioblastoma multiforme (GBM) Novartis Pharma AG
• A Phase 2 Study to Investigate Efficacy and Safety of HZN-1116 in Participants With Sjögren’s Syndrome Ended
  2023-507680-19-00 Phase II Sjögren’s Syndrome Horizon Therapeutics Ireland Designated Activity Company
• Study to evaluate food effect on the pharmacokinetics of mesalazine oral formulation in healthy volunteers. Ended
  2024-514748-10-00 Phase I (Other) Ulcerative colitis Faes Farma S.A.
• Phleum pratense and Dactylis glomerata allergen extracts. Determination of the in vivo histamine equivalent prick test units. Ended
  2024-514215-98-00 Phase II Allergy to Phleum pratense and Dactylis glomerata. Inmunotek S.L.
• A Double-Blind, Randomized, Multicenter, Trial Evaluating the Efficacy and Safety of PRAX-628 in Adults with Focal Seizures (POWER 1) Ended
  2024-514559-13-00 Phase II/III Focal Epilepsy Praxis Precision Medicines Inc.
• A 14-week, multicentre, double-blind, randomised, placebo-controlled phase II study with an 8-week treatment period to assess the efficacy a… Ended
  2024-513104-34-00 Phase II Major Depressive Disorder HMNC Holding GmbH
• Bioequivalence clinical trial of two formulations of linagliptin/metformin Ended
  2024-515076-13-00 Healthy volunteers Laboratorios Normon S.A.
• A Phase 1/2 Study of VX-522 in Subjects with Cystic Fibrosis Ended
  2023-504786-23-00 Phase I (FiH) Cystic Fibrosis Vertex Pharmaceuticals Inc.
• Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety and Efficacy of Melatonin Administration in Patients With… Ended
  2023-508457-10-00 Phase I (FiH) Primary Progressive Multiple Sclerosis Fundacion Publica Andaluza Para La Gestion De La Investigacion En Salud De Sevil…
• A multicentre clinical trial to assess the safety and tolerability of the combination of low-dose cytarabine or azacitidine, plus Venetoclax… Ended
  2024-519275-26-00 Phase I/II Newly diagnosed acute myeloid leukemia patients aged equal o… Fundacion PETHEMA
• A Clinical Study in which patients with acne vulgaris will receive a new topical drug. The safety and efficacy of the drug will be tested. Ended
  2023-510341-19-00 Phase III acne vulgaris PPM Services S.A.
• A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as … Ended
  2024-511557-21-00 Phase III Major Depressive Disorder (MDD) with Moderate-to-severe Anhe… Janssen Cilag International
• A study on the safety of and immune response to different doses of an mRNA vaccine against RSV in healthy adults. Ended
  2024-512846-41-00 Phase I Respiratory Syncytial Virus Infections GlaxoSmithKline Biologicals
• A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Letrozole Compared to Letrozole Alone in Postmenopausal Wom… Ended
  2024-512848-30-00 Phase II HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE BREAST CANCER Pfizer Inc.
• Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHIN… Ended
  2023-508812-45-00 Phase II/III Idiopathic Generalized Epilepsy with Generalized Tonic-cloni… Biohaven Therapeutics Ltd.
• A Clinical Study in which patients with acne vulgaris will receive a new topical drug. The safety and efficacy of the drug will be tested. Ended
  2023-510339-12-00 Phase III acne vulgaris PPM Services S.A.
• Randomized clinical trial comparing the diagnostic quality and diagnostic accuracy of pulmonary CT angiography performed with spectral CT am… Ended
  2024-515246-17-00 Phase IV pulmonary embolism Hospital General Universitario Dr. Balmis

Showing 3,625–3,648 of 4,859 trials